Skip to content

Clinical trials

Observational Kidney Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Observational Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20033
20042
20053
20062
20071
20081
20093
20102
20134
20143
20151
20161
20173
20183
20191
20204
20215
20224
20231
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting16
Terminated7
Active, not recruiting5
Unknown status3
Not yet recruiting2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
M.D. Anderson Cancer Center4
Memorial Sloan Kettering Cancer Center3
A2 Biotherapeutics Inc.2
Children's Oncology Group2
Duke University2
Elephas2
Harvard Medical School (HMS and HSDM)2
University of Nebraska2
Wake Forest University Health Sciences2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms62
Carcinoma, Renal Cell21
Urinary Bladder Neoplasms19
Prostatic Neoplasms16
Lung Neoplasms15
Pancreatic Neoplasms15
Neoplasms14
Liver Neoplasms13
Head and Neck Neoplasms12
Ovarian Neoplasms12

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.